Notice: Undefined variable: blnIsHomepage in /usr/local/apache/htdocs/igatecr/template/template_1.php on line 17
class="pgContentScroll" style="width: 589px;">
The study was a 90-day, multi-center, double-blind, randomized, add-on study to evaluate the safety and efficacy of low and high dose of oral insulin/4-CNAB tablets versus placebo in subjects with type II Diabetes Mellitus who have inadequate glycemic control with metformin monotherapy.
class="pgContentScroll" style="width: 589px;">
Case Studies
iGATE Clinical Research recently completed a Phase IIb trial in type II diabetic patients for a NASDAQ-listed pharma company based in the United States.The study was a 90-day, multi-center, double-blind, randomized, add-on study to evaluate the safety and efficacy of low and high dose of oral insulin/4-CNAB tablets versus placebo in subjects with type II Diabetes Mellitus who have inadequate glycemic control with metformin monotherapy.
Due to India's large diabetic population and iGATE CR's outstanding patient recruitment capabilities, enrollment for this trial was completed at seven centers across India within just five months.
Please read more about this trial by downloading our case study.
